** Shares of Belgian semiconductor firm Melexis MLXS.BR drop
about 13% to the bottom of Belgium's blue-chip index BEL20
.BFX after it reported results and guidance below expectations
** Melexis reports Q4 oper margin of 14.0% on sales of 197.4
mln euros ($205.28 mln) vs a company-compiled consensus of
18.6% and 205.4 mln euros
** The shares, which touch their lowest price since mid-Mary
2020, are on track for their worst day since end-Oct 2018
** Degroof Petercam's Michael Roeg says the results and
outlook are well below expectations across the board
** Melexis sees H1 oper margin of about 16% on sales of
arounf 400 mln euros, both down y/y
** It keeps 2024 sales target of 1 billion euros, while
inventory corrections are continuing in 2025
** Roeg adds investors would be looking at the management's
confidence regarding the second half improvement during the
post-earnings call
** "We expect the market to look beyond near-term weakness
and should start pricing in the next upcycle," analysts at KBC
Securities add
($1 = 0.9616 euros)
(Reporting by Nathan Vifflin)
((nathan.vifflin@thomsonreuters.com; +48 58 769 67 13;))